Huntington National Bank »

Rigel Pharmaceuticals shares owned by Huntington National Bank

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $1 1 1.00

More positions owned by Huntington National Bank

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Jp Morgan Chase & Co Common Stock (JPM)
Nvidia Corp Common Stock (NVDA)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IJR)
Alphabet Common Stock (GOOGL)
Ishares Exchange Traded (Principal) (IJH)
Ishares Exchange Traded (Principal) (IVW)
Amazon.com Common Stock (AMZN)
Eli Lilly & Co Common Stock (LLY)
Ishares Exchange Traded (Principal) (IVE)
Visa Common Stock (V)
Exxon Mobil Corp Common Stock (XOM)
Spdr S&p 500 Etf Trust Exchange Traded (Principal) (SPY)

View all positions for Huntington National Bank

Top funds holding Rigel Pharmaceuticals

Soleus Capital Management
Vanguard Group
Jacobs Levy Equity Management
Assenagon Asset Management
CM Management
GSA Capital Partners
Sphera Funds Management
Millennium Management
Charles Schwab Investment Management
Two Sigma Advisers
Thomas Stevens, CFA"
Connor, Clark & Lunn Investment Management
Bank of New York Mellon
Goldman Sachs Group
Squarepoint Ops

View all funds holding Rigel Pharmaceuticals